focus -WSS

focus

author：Wikipedia 2025-09-27 23:02:19 - browse：28881

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an insurance network. It comes just weeks after the New York Times published an investigation detailing how MultiPlan and its insurance company clients make more money by low-balling payments to hospitals.

The lawsuit further lays bare some of the warped incentives that exist within the health care system: out-of-network providers billing inflated amounts, insurers profiting by making sure those payments are as low as possible, and patients stuck in the middle with bills they often cannot afford.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Late stage cancers on the rise after pandemic delayed screenings

WSS

The a glaring gap in research on serious mental illness and primary care

Group behind ProMed defends move to subscription

Medicare slashes safety net hospital payments by nearly $1 billion

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Why depression after traumatic brain injury is distinct

FDA approves Sage Therapeutics’ rapid

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Trump demands the U.S. pay no more for drugs than other countries … again

First U.S. drug developed to treat liver disease MASH is approved

After affirmative action ruling, medical educators look to 'holistic review'

A controversial new treatment promises to make little people taller

Malaria cases in Florida and Texas: Here’s what you need to know

The a glaring gap in research on serious mental illness and primary care

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

When waiting feels immoral: Empathy in the emergency department

Psychedelics group wrestles with new pharma identity

Biotech startup Celsius cuts 75% of staff ahead of first trial start

leisure time

President Biden's budget: Here's what you might have missed

The a glaring gap in research on serious mental illness and primary care

When waiting feels immoral: Empathy in the emergency department

President Biden's budget: Here's what you might have missed

How many hemophilia patients actually want gene therapy?

It costs an awful lot of money to give away a kidney

Wikipedia

focus

knowledge

entertainment